Distribution agreements often lead to increased sales and market penetration, which can positively impact a company's financial outlook and investor sentiment. The partnership with a well-established company like Thermo Fisher Scientific is likely to be viewed positively by investors, leading to potential short-term gains in Bio-Techne's stock price.

While Thermo Fisher Scientific is a much larger entity than Bio-Techne, the distribution agreement could still be seen as a positive development, albeit with a lesser impact due to the relative size of the companies. The deal may enhance Thermo Fisher's product distribution capabilities and market reach, potentially leading to a slight increase in its stock price.